Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07507370 · ClinicalTrials.gov registry record · NA
CARED : A Novel Rapid Treatment Paradigm for Depression
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07507370 is a NA study that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants.
The verdict
NCT07507370, a NA study, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to primarily assess the feasibility and secondarily assess the efficacy of a single session intervention (SSI) that combines non-invasive brain stimulation and psychotherapy for Major Depressive Disorder (MDD). investigators will recruit 30 people with MDD, with at least mild to moderate symptoms, who are resistant to typical treatments for Major Depressive Disorder. In this trial, participants will receive psychotherapy, Intermittent Theta Burst Stimulation Transcranial Magnetic Stimulation (iTBS), and either active or sham (placebo) Transcranial Alternating Current Stimulation (tACS).
Interventions
- BEHAVIORAL Psychotherapy
- DEVICE Transcranial Alternating Current Stimulation (tACS)
- DEVICE Intermittent Theta Burst Stimulation (iTBS)
- DEVICE Sham (Placebo) Transcranial Alternating Current Stimulation (tACS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-14 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07507370
The ClinicalTrials.gov registry entry for NCT07507370 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Psychotherapy is the first listed.
NCT07507370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07507370 about?
NCT07507370 is a clinical study titled "CARED : A Novel Rapid Treatment Paradigm for Depression". The purpose of this study is to primarily assess the feasibility and secondarily assess the efficacy of a single session intervention (SSI) that combines non-invasive brain stimulation and psychotherapy for Major Depressive Disorder (MDD). investigators will recruit 30 people with MDD, with at least...
What is the current status of trial NCT07507370?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-04-14. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07507370?
The interventions under investigation include: Psychotherapy (BEHAVIORAL), Transcranial Alternating Current Stimulation (tACS) (DEVICE), Intermittent Theta Burst Stimulation (iTBS) (DEVICE), Sham (Placebo) Transcranial Alternating Current Stimulation (tACS) (DEVICE).
Who is sponsoring clinical trial NCT07507370?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.